SCHEMBL7662981

SCHEMBL7662981

CC(Cc1cnc2ccccc2c1)(C(=O)NCc1ccccc1)N(C(=O)O)C1C2CC3CC(C2)CC1C3

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 3/20 0.39
TACR1 P25103 1/20 0.38
TACR3 P29371 1/20 0.38
KDM1A O60341 1/20 0.38
MAOA P21397 1/20 0.38
MAOB P27338 1/20 0.38
CCKBR P32239 1/20 0.37
CFTR P13569 1/20 0.37
HDAC3 O15379 2/20 0.37
HDAC1 Q13547 2/20 0.37
HDAC2 Q92769 2/20 0.37
FAAH O00519 2/20 0.35
HPGD P15428 1/20 0.35
HDAC6 Q9UBN7 2/20 0.35
HPGDS O60760 1/20 0.35
HDAC4 P56524 1/20 0.35
HDAC7 Q8WUI4 1/20 0.35
HDAC10 Q969S8 1/20 0.35
HDAC11 Q96DB2 1/20 0.35
HDAC8 Q9BY41 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7667767 0.78 EPHX2 (0.44) EPHX2CCKBRMMP8
SCHEMBL7670293 0.75 EPHX2 (0.41) EPHX2CCKBRHDAC1HDAC2MMP8
SCHEMBL7667387 0.73 CCKBR (0.46) EPHX2CCKBR
SCHEMBL9699696 0.73 RIPK1 (0.43) TACR1TACR3CFTRHDAC3HDAC1
SCHEMBL9538804 0.71 HPGDS (0.42) CFTRHDAC3HDAC1HDAC2HPGD
SCHEMBL7672037 0.70 CCKBR (0.46) EPHX2CCKBRMMP8
SCHEMBL7671034 0.69 EPHX2 (0.44) EPHX2CCKBRMMP8
SCHEMBL7662533 0.69 CCKBR (0.47) CCKBR
SCHEMBL7665154 0.69 CCKBR (0.35) CCKBRMAPK1
SCHEMBL6890533 0.68 CCKBR (0.64) CCKBR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1993003721-A1 CHOLECYSTOKININ ANTAGONISTS USEFUL FOR TREATING DEPRESSION WARNER-LAMBERT COMPANY (US) 1993-03-04 WO claimed
US-6492531-B1 THE INVENTION CONCERNS CHOLECYSTOKININ (CCK) ANTAGONISTS USEFUL IN THE TREATMENT OF COGNITIVE DISORDERS. ESPECIALLY USEFUL ARE CCK.SUB.B ANTAGONISTS SUCH AS CI-988. WARNER-LAMBERT COMPANY 2002-12-10 US disclosed